The global pharmacovigilance (PV) or drug safety market is projected to grow from $8.6bn in 2024 to $22.4bn by 2032.

The 2020s have seen periods of heightened market turmoil not seen since 2011 and 2008. The impacts of the Covid-19 pandemic, the war on Ukraine and now additional geopolitical events including trade and tariff wars, have presented significant challenges for corporates. How should they respond strategically and operationally? How should they best deploy their capital? Is now the time to seek acquisition opportunities? Or divestments?

Market Access is becoming more complex, prompting more pharmaceutical companies to outsource commercialisation services to specialised providers.

The global supply chain experienced unprecedented complexity during the COVID-19 pandemic, exposing instability — with the biggest impact on cash flow and working capital requirements — and its inconsistency in supply bases during a time of increasing demand.

Retailers are revealing greater optimism as the golden quarter approaches. With an improving economic outlook and rising consumer confidence, retailers await a stronger end to the calendar year.

Americans are deeply concerned about their financial futures—and our recent research highlights the urgency of addressing retirement income security.

Americans are deeply concerned about their financial futures—and our recent research highlights the urgency of addressing retirement income security.

To remain competitive, firms must embrace intelligent architectures that unify data, support reasoning capabilities, and enable proactive decision-making.

Welcome to another insightful episode of Perspective First, where A&M experts explore the latest trends and developments in the financial services sector.

Introducing A&M AMPLIFIERS, a new video series from A&MPLIFY that brings together business leaders and innovators to discuss real AI use cases across industries...

A vision to nurture and scale a new category in the care delivery ecosystem and create a health information fiduciary is the innovative Moonshot of our most recent...

A&M Healthcare Industry Group has developed and launched Community Enrichment Solutions (CES), a pro bono initiative designed to help improve the access, quality...

The next era of healthcare innovation will depend on bold, visionary leadership from health plans. Hillary Galyean, Chief Growth Officer at St. Luke's Health Plan...

A growing quick-service restaurant hypothesized there was an opportunity to improve and enrich its brand and customer base within the market by implementing digital...

In his State of the Union address, President Biden made the case for requiring the majority of materials on federally funded infrastructure programs to be American made.

This article continues a discussion on the trends transforming how organizations operate, compete and thrive in an interconnected world.

On 6 August 2025, the German Federal Ministry of Finance has published a ministerial draft containing several amendments to existing tax regulations.

The Internal Revenue Service (IRS) has announced that its compliance efforts have protected over $1 billion in revenue since last fall, focusing on erroneous Employee Retention Credit (ERC) claims.

Over the last few years, AI has been in action. With dynamic pricing, predictive maintenance and real-time optimizations, AI is actively reshaping industries.

Our latest A&M Activist Alert ("AAA") report reviews how successful shareholder activists have been at choosing their targets, and how such activism will evolve in Europe through 2024.